ING4 Protein, Human (His)

ING4 protein is a component of the HBO1 complex and mediates acetylation of histone H3 at “Lys-14” while reducing the activity of histone H4. ING4 suppresses tumor progression by modulating signaling pathways, inhibiting brain tumor angiogenesis, and specifically inhibiting loss of contact inhibition of oncogenes such as MYC. ING4 Protein, Human (His) is the recombinant human-derived ING4 protein, expressed by E. coli , with N-His labeled tag.

ING4 is a vital component of HBO1 complexes, orchestrating the acetylation of histone H3 at 'Lys-14' (H3K14ac) while displaying reduced activity toward histone H4. Its involvement in chromatin acetylation suggests a potential role in DNA replication. Functionally, ING4 demonstrates tumor-suppressive properties by modulating the transcriptional output of signaling pathways that regulate cell proliferation. Notably, it can suppress brain tumor angiogenesis through transcriptional repression of RELA/NFKB3 target genes when forming a complex with RELA, and it exhibits the capacity to inhibit the loss of contact inhibition induced by activated oncogenes like MYC. ING4's repertoire extends to the repression of hypoxia-inducible factor (HIF) activity through interaction with HIF prolyl hydroxylase 2 (EGLN1), ultimately contributing to diverse cellular processes. The structural context involves ING4's homodimeric form and its association within the HBO1 complex, which includes KAT7/HBO1, MEAF6, and scaffold subunits BRPF or JADE, directing its specificity towards distinct histone acetylation targets. Furthermore, ING4 engages in interactions with histone modifications, EP300, RELA, TP53, and EGLN1, showcasing its intricate involvement in various cellular pathways and protein networks.

Human

E. coli

N-His

Q9UNL4-1 (M1-K249)

51147  [NCBI]

Approximately 31 kDa

Greater than 85% as determined by reducing SDS-PAGE.

<1 EU/μg, determined by LAL method.